相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Slit2 Regulates Hyaluronan & Cytokine Synthesis in Fibrocytes: Potential Relevance to Thyroid-Associated Ophthalmopathy
Roshini Fernando et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Slit2 Regulation of Hyaluronan and Cytokine Synthesis in Fibrocytes in Thyroid-associated Ophthalmopathy Comment
Alessandro Antonelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
The effects of Rituximab on Graves'orbitopathy: A retrospective study of 14 patients
Laura Eid et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2020)
Novel therapies for thyroid autoimmune diseases: An update
Silvia Martina Ferrari et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Graves' disease: Epidemiology, genetic and environmental risk factors and viruses
Alessandro Antonelli et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy
Alessandro Antonelli et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy
Terry J. Smith
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease
George J. Kahaly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Th1 Chemokines in Autoimmune Endocrine Disorders
Poupak Fallahi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Tocilizumab for the Management of Corticosteroid-Resistant Mild to Severe Graves' Ophthalmopathy, a Report of Three Cases
Thomas Maldiney et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2020)
Slit2 May Underlie Divergent Induction by Thyrotropin of IL-23 and IL-12 in Human Fibrocytes
Roshini Fernando et al.
JOURNAL OF IMMUNOLOGY (2020)
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
Peter N. Taylor et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Teprotumumab for the Treatment of Active Thyroid Eye Disease
R. S. Douglas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Graves' disease
Terry F. Davies et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in anin vitromodel
Hyeong Ju Byeon et al.
PLOS ONE (2020)
Low-Dose Rituximab for Active Moderate to Severe Graves' Orbitopathy Resistant to Conventional Treatment
Laurence Du Pasquier-Fediaevsky et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2019)
Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy
Terry J. Smith et al.
ENDOCRINE REVIEWS (2019)
Early low-dose rituximab for active thyroid eye disease: An effective and well-tolerated treatment
Elizabeth A. Insull et al.
CLINICAL ENDOCRINOLOGY (2019)
Differential modulation of CXCL8 versus CXCL10, by cytokines, PPAR-gamma, or PPAR-alpha agonists, in primary cells from Graves' disease and ophthalmopathy
Silvia Martina Ferrari et al.
AUTOIMMUNITY REVIEWS (2019)
Immunotherapies for thyroid eye disease
George J. Kahaly
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2019)
Immune and Inflammatory Cells in Thyroid Cancer Microenvironment
Silvia Martina Ferrari et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Immunological Aspects of Graves' Ophthalmopathy
Dominika Lacheta et al.
BIOMED RESEARCH INTERNATIONAL (2019)
The association of other autoimmune diseases in patients with Graves' disease (with or without ophthalmopathy): Review of the literature and report of a large series
Silvia Martina Ferrari et al.
AUTOIMMUNITY REVIEWS (2019)
Current and Emerging Treatment Strategies for Graves' Orbitopathy
Natalia Genere et al.
DRUGS (2019)
Potential Roles of CD34+ Fibrocytes Masquerading as Orbital Fibroblasts in Thyroid-Associated Ophthalmopathy
Terry J. Smith
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Chemokines in hyperthyroidism
Silvia Martina Ferrari et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2019)
Etanercept in the treatment of Graves' ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
Olivera Boskovic et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
Advances in the management of thyroid eye diseases: An overview
Rashmi Kumari et al.
INTERNATIONAL OPHTHALMOLOGY (2018)
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
Ryuma Tokunaga et al.
CANCER TREATMENT REVIEWS (2018)
Thyrotropin Receptor Antibodies—An Overview
Anupam Kotwal et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2018)
Efficacy and Safety of Immunosuppressive Agents for Thyroid Eye Disease
Diego Strianese
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2018)
Efficacy and Safety of Rituximab for the Treatment of Graves' Orbitopathy: A Meta-analysis of Randomized Controlled Trials
Wan-Chen Shen et al.
PHARMACOTHERAPY (2018)
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy
Giovanna Rotondo Dottore et al.
JAMA OPHTHALMOLOGY (2018)
Graves' disease: Introduction, epidemiology, endogenous and environmental pathogenic factors
Jean-louis Wemeau et al.
ANNALES D ENDOCRINOLOGIE (2018)
Teprotumumab for Thyroid-Associated Ophthalmopathy
Terry J. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement
P. Perros et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?
L. Bartalena et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
Building the Case for insulin-Like Growth Factor Receptor-I involvement in Thyroid-Associated Ophthalmopathy
Terry J. Smith et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Update on Graves disease: advances in treatment of mild, moderate and severe thyroid eye disease
Diego Strianese
CURRENT OPINION IN OPHTHALMOLOGY (2017)
Inhibiting thyrotropin/insulin-like growth factor 1 receptor crosstalk to treat Graves' ophthalmopathy: studies in orbital fibroblasts in vitro
Robert F. Place et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Smoke and autoimmunity: The fire behind the disease
Carlo Perricone et al.
AUTOIMMUNITY REVIEWS (2016)
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients
Poupak Fallahi et al.
AUTOIMMUNITY REVIEWS (2016)
Graves' Disease
Terry J. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Novel Therapies for Thyroid Autoimmune Diseases
Poupak Fallahi et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy
Luigi Bartalena et al.
EUROPEAN THYROID JOURNAL (2016)
Thyroid eye disease- an update
Mohd Shazli Draman et al.
EXPERT REVIEW OF OPHTHALMOLOGY (2016)
IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy
Sijie Fang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2016)
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature
Dilia Giuggioli et al.
AUTOIMMUNITY REVIEWS (2015)
Autoimmune thyroid disorders
Alessandro Antonelli et al.
AUTOIMMUNITY REVIEWS (2015)
Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
Marius N. Stan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Efficacy of B-Cell Targeted Therapy With Rituximab in Patients With Active Moderate to Severe Graves' Orbitopathy: A Randomized Controlled Study
Mario Salvi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Extra-ocular muscle cells from patients with Graves' ophthalmopathy secrete α (CXCL10) and β (CCL2) chemokines under the influence of cytokines that are modulated by PPARγ
Alessandro Antonelli et al.
AUTOIMMUNITY REVIEWS (2014)
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases
Alessandro Antonelli et al.
AUTOIMMUNITY REVIEWS (2014)
Breaking Tolerance to Thyroid Antigens: Changing Concepts in Thyroid Autoimmunity
Sandra M. McLachlan et al.
ENDOCRINE REVIEWS (2014)
The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD)
Hanna Mikos et al.
ENDOKRYNOLOGIA POLSKA (2014)
A Prospective, Randomized Trial of Intravenous Glucocorticoids Therapy With Different Protocols for Patients With Graves' Ophthalmopathy
Wei Zhu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes
Hong Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Treatment of Active Corticosteroid-Resistant Graves' Orbitopathy
Jose Vicente Perez-Moreiras et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
Adalimumab as Steroid-Sparing Treatment of Inflammatory-Stage Thyroid Eye Disease
Reed Ayabe et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
Therapeutic Outcomes of High-Dose Intravenous Steroids in the Treatment of Dysthyroid Optic Neuropathy
Nicola Curro et al.
THYROID (2014)
Diagnosis and management of thyrotoxicosis
Bijay Vaidya et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
A Small Molecule Antagonist Inhibits Thyrotropin Receptor Antibody-Induced Orbital Fibroblast Functions Involved in the Pathogenesis of Graves Ophthalmopathy
Adina F. Turcu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer
Alessandro Antonelli et al.
CYTOKINE (2012)
Efficacy and Safety of Orbital Radiotherapy for Graves' Orbitopathy
Maria Laura Tanda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Prostaglandin E2 Activates and Utilizes mTORC2 as a Central Signaling Locus for the Regulation of Mast Cell Chemotaxis and Mediator Release
Hye Sun Kuehn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Increase of Circulating CXCL9 and CXCL11 Associated with Euthyroid or Subclinically Hypothyroid Autoimmune Thyroiditis
Alessandro Antonelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Intravenous Glucocorticoids for Graves' Orbitopathy: Efficacy and Morbidity
S. Zang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody
Paul Sanders et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2011)
Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone
Alessandro Antonelli et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: Modulation by peroxisome proliferator-activated receptor-gamma agonists
Alessandro Antonelli et al.
CYTOKINE (2010)
The Expression of Intercellular Adhesion Molecule-1 Induced by CD40-CD40L Ligand Signaling in Orbital Fibroblasts in Patients with Graves' Ophthalmopathy
Li-Quan Zhao et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Monokine Induced by Interferon γ(IFNγ) (CXCL9) and IFNγ Inducible T-Cell α-Chemoattractant (CXCL11) Involvement in Graves' Disease and Ophthalmopathy: Modulation by Peroxisome Proliferator-Activated Receptor-γ Agonists
Alessandro Antonelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Orbital Fibroblasts from Patients with Thyroid-Associated Ophthalmopathy Overexpress CD40: CD154 Hyperinduces IL-6, IL-8, and MCP-1
Catherine J. Hwang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
High values of alpha (CXCL10) and beta (CCL2) circulating chemokines in patients with psoriatic arthritis, in presence or absence of autoimmune thyroiditis
Alessandro Antonelli et al.
AUTOIMMUNITY (2008)
Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy
Mei-Hsiu Chen et al.
CLINICAL ENDOCRINOLOGY (2008)
Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link
T. J. Cawood et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process
A Antonelli et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Interferon-γ-inducible α-chemokine CXCL10 involvement in Graves' ophthalmopathy:: Modulation by peroxisome proliferator-activated receptor-γ agonists
A Antonelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E-2 and hyaluronan synthesis by interleukin-1 beta in orbital fibroblasts: Implications for the pathogenesis of thyroid-associated ophthalmopathy
R Han et al.
ENDOCRINOLOGY (2006)
The effect of etanercept on Graves' ophthalmopathy: a pilot study
D Paridaens et al.
EYE (2005)
IL-1β induces IL-6 expression in human orbital fibroblasts:: Identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy
BL Chen et al.
JOURNAL OF IMMUNOLOGY (2005)
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4
L Lasagni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease
M Ludgate et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking
M Salvi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
分享论文
